Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03958903 · ClinicalTrials.gov registry record · NA
Investigations of Amygdala Function Using Neurophysiological Recording and Stimulation
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT03958903: Completed NA study, sponsored by Stanford University.
NCT03958903 is a NA study that has completed, run by Stanford University. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03958903, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
This study aims to specifically examine the in vivo electrophysiology and effects of direct stimulation of the human amygdala during conditioned and evoked fear. Investigators will also examine amygdala electrophysiology and the effects of stimulation during tasks to examine the effects of reward on fear memory. This study will recruit subjects with a history of temporal lobe epilepsy (TLE) who have undergone neurosurgical implantation with FDA-approved, NeuroPace RNS devices for treatment of seizures. These patients provide a unique cohort with (Responsive Neurostimulation) RNS devices capable of both recording and stimulating the amygdala during performance of fear-based, behavioral tasks.
Interventions
- DEVICE Amygdala recording and stimulation using Neuropace RNS
- BEHAVIORAL Behavioral tasks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2019-04-24 |
| Est. Completion | 2020-03-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03958903
The ClinicalTrials.gov registry entry for NCT03958903 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Amygdala recording and stimulation using Neuropace RNS is the first listed.
NCT03958903 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03958903 about?
NCT03958903 is a clinical study titled "Investigations of Amygdala Function Using Neurophysiological Recording and Stimulation". This study aims to specifically examine the in vivo electrophysiology and effects of direct stimulation of the human amygdala during conditioned and evoked fear. Investigators will also examine amygdala electrophysiology and the effects of stimulation during tasks to examine the effects of reward on...
What is the current status of trial NCT03958903?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2019-04-24. Estimated completion is 2020-03-13.
What interventions are being tested in trial NCT03958903?
The interventions under investigation include: Amygdala recording and stimulation using Neuropace RNS (DEVICE), Behavioral tasks (BEHAVIORAL).
Who is sponsoring clinical trial NCT03958903?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.